Medical vulnerability of individuals with Down syndrome to severe COVID-19–data from the Trisomy 21 Research Society and the UK ISARIC4C survey

BACKGROUND: Health conditions, immune dysfunction, and premature aging associated with trisomy 21 (Down syndrome, DS) may impact the clinical course of COVID-19. METHODS: The T21RS COVID-19 Initiative launched an international survey for clinicians or caregivers on patients with COVID-19 and DS. Dat...

Descripción completa

Detalles Bibliográficos
Autores principales: Hüls, Anke, Costa, Alberto C.S., Dierssen, Mara, Baksh, R. Asaad, Bargagna, Stefania, Baumer, Nicole T., Brandão, Ana Claudia, Carfi, Angelo, Carmona-Iragui, Maria, Chicoine, Brian Allen, Ghosh, Sujay, Lakhanpaul, Monica, Manso, Coral, Mayer, Miguel-Angel, Ortega, Maria del Carmen, de Asua, Diego Real, Rebillat, Anne-Sophie, Russell, Lauren Ashley, Sgandurra, Giuseppina, Valentini, Diletta, Sherman, Stephanie L., Strydom, Andre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7897934/
https://www.ncbi.nlm.nih.gov/pubmed/33644721
http://dx.doi.org/10.1016/j.eclinm.2021.100769

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7897934/
https://www.ncbi.nlm.nih.gov/pubmed/33644721
http://dx.doi.org/10.1016/j.eclinm.2021.100769

Ejemplares similares